The role of inflammation mediators in bronchial asthma and chronic obstructive pulmonary disease
Chciałowski, A.; Targowski, T.
Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 6(31): 1-4
1999
ISSN/ISBN: 1426-9686 PMID: 10344143 Document Number: 505366
Bronchial asthma and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases of the bronchial tree. Some products of eosinophils, neutrophils and other cells have been implicated in causing bronchial mucosal damage and may play important role in monitoring degree of airway inflammation and differentiation between bronchial asthma and COPD. The author described some of them.
Document emailed within 1 workday
Related Documents
Liebhart, J.; Dor, A. 1998: Diagnostic standard for differentiation between bronchial asthma and chronic obstructive pulmonary disease Pneumonologia i Alergologia Polska 66(7-8): 373-382Dotsenko, E.K.; Goncharova, V.A.; Kuzubova, N.A.; Kamenova, M.Iu.; Egorova, N.V. 2008: The role of expired air moisture condensate in assessment of pulmonary inflammation in patients with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 80(3): 10-14
Sadlonova, J.; Korpas, J.; Vrabec, M.; Salat, D.; Buchancova, J.; Kudlicka, J. 2002: The effect of the pulsatile electromagnetic field in patients suffering from chronic obstructive pulmonary disease and bronchial asthma Bratislavske Lekarske Listy 103(7-8): 260-265
Dor, A.; Krasnowska, M.; Małolepszy, J. 1994: Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma Pneumonologia i Alergologia Polska 62(1-2): 75-79
Malerba, M.; Radaeli, A.; Mancuso, S.; Polosa, R. 2010: The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease Journal of Biological Regulators and Homeostatic Agents 24(2): 123-130
Burgaud, J.L. 2001: Inflammation 2001--fifth world congress. Chronic obstructive pulmonary disease IDrugs: the investigational drugs journal 4(11): 1208-1209
Hogg, J.C. 1993: Bronchiolitis in asthma and chronic obstructive pulmonary disease Clinics in Chest Medicine 14(4): 733-740
Ten Hacken, N.H.; Postma, D.S.; Timens, W. 1999: Are asthma and chronic obstructive pulmonary disease different diseases?--Con Monaldi Archives for Chest Disease 54(6): 551-558
Volchkova, E.A.; Zateĭshchikova, A.A.; Shavrin, I.V.; Kiselev, D.G.; Brazhnik, V.A.; Privalov, D.V.; Doshchitsin, V.L.; Zateĭshchikov, D.A. 2012: Association of parameters of heart rate variability with severity of bronchial obstruction and presence of pulmonary hypertension in patients with chronic obstructive pulmonary disease Kardiologiia 52(7): 42-49
Sherter, C.B. 1983: The use of corticosteroids in asthma, bronchitis and chronic obstructive pulmonary disease Connecticut Medicine 47(7): 389-392
Nishiyama, O.; Tohda, Y. 2014: Diagnostic differences in asthma and chronic obstructive pulmonary disease Rinsho Byori. Japanese Journal of Clinical Pathology 62(5): 457-463
Karwat, K.J.; Szpotańska, M.; Szulc, Z.; Chazan, R. 2006: The influence of influenza vaccination on asthma and chronic obstructive pulmonary disease Pneumonologia i Alergologia Polska 74(1): 80-83
Balantic, M.; Rijavec, M.; Flezar, M.; Camlek, T.; Hudoklin, I.; Kosnik, M.; Korosec, P.; Suskovic, S. 2013: A polymorphism in ORMDL3 is associated not only with asthma without rhinitis but also with chronic obstructive pulmonary disease Journal of Investigational Allergology and Clinical Immunology 23(4): 256-261
Walters, E.Haydn.; Wood-Baker, R. 2008: Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia Medical Journal of Australia 188(4): 258; Author Reply 258-9
Azzouzi, N.; Elhataoui, M.; Bakhatar, A.; Takourt, B.; Benslimane, A. 2005: Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma Annales de Biologie Clinique 63(2): 179-184
Skorodin, M.S. 1993: Pharmacotherapy for asthma and chronic obstructive pulmonary disease. Current thinking, practices, and controversies Archives of Internal Medicine 153(7): 814-828
Yoshizawa, A.; Kamimura, M.; Sugiyama, H.; Kudo, K.; Kabe, J. 1996: Eosinophil cationic protein in serum from adults with asthma and with chronic obstructive pulmonary disease Nihon Kyobu Shikkan Gakkai Zasshi 34(1): 24-29
Abubaker, J.; Zaina, F.; Siddiqui, S.; Zahid, M.; Ullah, S.Z.; Abubaker, Z.J.; Karim, M.; Ullah, S. 2019: Single Intramuscular Methylprednisolone dose in Asthma and Chronic Obstructive Pulmonary Disease Patients on Discharge JPMA. Journal of the Pakistan Medical Association 69(7): 991-994
Rühle, K.H. 1987: Sleep and endangered respiration in bronchial asthma, chronic obstructive lung disease and lung fibrosis Praxis und Klinik der Pneumologie 41(10): 438-441
Mosiewicz, J.; Myśliński, W.; Ryczak, E.; Dzida, G.; Biłan, A.; Palusiński, R.; Hanzlik, J. 1999: Bronchial hyperreactivity as a factors of chronic obstructive pulmonary disease development in the population of the Bogdanka coal miners Medycyna Pracy 50(6): 537-547